Literature DB >> 9691109

Bisphosphonates as anticancer drugs.

G R Mundy, T Yoneda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9691109     DOI： 10.1056/NEJM199808063390609

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  20 in total

Review 1.  Gene targeting to the stroma of the prostate and bone.

Authors:  Roger S Jackson; Omar E Franco; Neil A Bhowmick
Journal:  Differentiation       Date:  2008-05-20       Impact factor: 3.880

2.  Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial.

Authors:  Alexander H G Paterson; Stewart J Anderson; Barry C Lembersky; Louis Fehrenbacher; Carla I Falkson; Karen M King; Lorna M Weir; Adam M Brufsky; Shaker Dakhil; Thomas Lad; Luis Baez-Diaz; Julie R Gralow; André Robidoux; Edith A Perez; Ping Zheng; Charles E Geyer; Sandra M Swain; Joseph P Costantino; Eleftherios P Mamounas; Norman Wolmark
Journal:  Lancet Oncol       Date:  2012-06-14       Impact factor: 41.316

Review 3.  Clodronate: a review of its use in breast cancer.

Authors:  M Hurst; S Noble
Journal:  Drugs Aging       Date:  1999-08       Impact factor: 3.923

4.  Guanosine nucleotides inhibit different syndromes of PTHrP excess caused by human cancers in vivo.

Authors:  Wolfgang E Gallwitz; Theresa A Guise; Gregory R Mundy
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

5.  Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression.

Authors:  R N Pearse; E M Sordillo; S Yaccoby; B R Wong; D F Liau; N Colman; J Michaeli; J Epstein; Y Choi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

Review 6.  Future directions of bone-targeted therapy for metastatic breast cancer.

Authors:  Tomifumi Onishi; Naoki Hayashi; Richard L Theriault; Gabriel N Hortobagyi; Naoto T Ueno
Journal:  Nat Rev Clin Oncol       Date:  2010-08-31       Impact factor: 66.675

Review 7.  Bisphosphonate treatment and radiotherapy in metastatic breast cancer.

Authors:  A Ugur Ural; Ferit Avcu; Yusuf Baran
Journal:  Med Oncol       Date:  2008-01-17       Impact factor: 3.064

8.  Biomechanical parameters of the BP-enriched bone cement.

Authors:  Łukasz Matuszewski; Grażyna Olchowik; Tomasz Mazurkiewicz; Bartłomiej Kowalczyk; Agata Zdrojewska; Anna Matuszewska; Andrzej Ciszewski; Małgorzata Gospodarek; Iwona Morawik
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-05-14

9.  The bisphosphonate zoledronic acid induces cytotoxicity in human myeloma cell lines with enhancing effects of dexamethasone and thalidomide.

Authors:  A Ugur Ural; M Ilker Yilmaz; Ferit Avcu; Aysel Pekel; Murat Zerman; Oral Nevruz; Ali Sengul; Atilla Yalcin
Journal:  Int J Hematol       Date:  2003-12       Impact factor: 2.490

10.  E2f3 in tumor macrophages promotes lung metastasis.

Authors:  P Trikha; N Sharma; C Pena; A Reyes; T Pécot; S Khurshid; M Rawahneh; J Moffitt; J A Stephens; S A Fernandez; M C Ostrowski; G Leone
Journal:  Oncogene       Date:  2015-11-09       Impact factor: 9.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.